GSK announces cap of $35 per month on U.S. patient out-of …

GSK Announces Cap Of $35 Per Month On U.S. Patient Out-of …

1 week from now

Mar 20, 2024  · Announcement builds on GSK’s decades-long commitment to making products accessible to those who need them; GSK today announced it will cap out-of-pocket costs for eligible patients at no more than $35 per month for all of its asthma and chronic obstructive …

gsk.com

GSK Follows Rivals, To Cap Out-of-Pocket Inhaler Cost In US

1 week from now

Mar 21, 2024  · GSK plc GSK announced plans to cap out-of-pocket expenses for its inhaled respiratory portfolio in the United States at $35 per month, following a similar move by rivals …

yahoo.com

GSK To Cap Out-of-pocket Inhaler Costs In US | Reuters

1 week from now

Mar 20, 2024  · British pharmaceutical giant GSK said on Wednesday it would cap out-of-pocket costs for all its inhaled asthma and chronic lung disease medicines at $35 per month for …

reuters.com

Drug Companies Step Forward With Voluntary Price Caps On Inhalers

1 week from now

Jun 2, 2024  · Drug companies Boehringer Ingelheim, AstraZeneca and GSK are capping out-of-pocket costs for their asthma inhalers at $35 per month for eligible patients. The price caps for …

allergyasthmanetwork.org

These Inhalers No Longer Cost More Than $35 Per Month

1 week from now

Amidst untenable drug prices, there's finally some good news: Several pharmaceutical companies are capping the out-of-pocket price of select inhalers at $35.. GlaxoSmithKline (GSK) is the …

msn.com

Some Drugmakers To Cap Cost Of Asthma Inhalers At $35 A Month

1 week from now

May 31, 2024  · Kiowa Rix, 27, of Warren, Michigan, found herself with a $500 out-of-pocket price tag for her son Lucas’ inhaler — Flovent, from GSK — in February, when her insurance …

nbcnews.com

GSK Follows Rivals, To Cap Out-of-Pocket Inhaler Cost In US

1 week from now

Mar 21, 2024  · However, GSK plans to start this in 2025. The British drugmaker is one of the biggest sellers of inhalers in the United States. Shares of GSK have gained 13.1% year to …

nasdaq.com

Major Drug Companies Cap Asthma Medication Costs At $35 Per …

1 week from now

Jun 26, 2024  · Major pharmaceutical companies have agreed to cap out-of-pocket costs for some asthma patients at $35 per month, a move that offers relief but doesn't fully address the larger …

wcvb.com

GSK Follows Rivals, To Cap Out-of-Pocket Inhaler Cost In US - MSN

1 week from now

Image Source: Zacks Investment Research. Earlier this week, AstraZeneca stated it would cap out-of-pocket expenses for all its inhaler products at $35 per month beginning in June 2024.

msn.com

Major Drugmakers Cap Price Of Asthma Inhalers - WSBT

1 week from now

Jun 12, 2024  · 2 major asthma inhaler drug makers Astra Zeneca and Boehringer Ingelheim have capped their out-of-pocket price for inhalers at just $35. ... inhaler sold in the US but just $26 …

wsbt.com

GSK To Cap Out-of-pocket Inhaler Costs In US - Dunya News

1 week from now

Mar 21, 2024  · (Reuters) – British pharmaceutical giant GSK said on Wednesday it would cap out-of-pocket costs for all its inhaled asthma and chronic lung disease medicines at $35 per month …

dunyanews.tv

GSK To Cap Out-of-pocket Inhaler Costs In US - The Mighty 790 KFGO

1 week from now

Mar 20, 2024  · (Reuters) - British pharmaceutical giant GSK said on Wednesday it will cap out-of-pocket costs at $35 per month for all its inhaled asthma and chronic lung disease medicines …

kfgo.com

Boehringer Ingelheim Caps Patient Out-of-pocket Costs For Its …

1 week from now

Ridgefield, Conn., March 7, 2024 – Boehringer Ingelheim today announced it will cap out-of-pocket costs at $35 per month for eligible patients i for all the company’s inhaler products. …

boehringer-ingelheim.com

‘Kids Need To Breathe Just Like Adults Do’: $35 Price Caps ... - CNN

1 week from now

Apr 17, 2024  · Some makers of asthma inhalers pledged to cap out-of-pocket costs for some US patients at $35. But those pledges don’t apply to daily inhalers used by the youngest kids,

cnn.com

AstraZeneca To Cap Out-of-pocket Inhaler Costs In US, Following …

1 week from now

Mar 18, 2024  · Drugmaker AstraZeneca said on Monday it would cap out-of-pocket costs for its inhaled respiratory products at $35 per month in the United States from June, following a …

reuters.com